Compile Data Set for Download or QSAR
Report error Found 350 Enz. Inhib. hit(s) with all data for entry = 1065
TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306556BDBM306556(US10144746, Compound 199 | (1R,8S)-N-[(4-carbamimi...)
Affinity DataIC50: 0.741nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306613BDBM306613(US10144746, Compound 256 | (1R,8S)-N-[(4-carbamimi...)
Affinity DataIC50: 0.759nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306637BDBM306637(US10144746, Compound 280 | (1R,8S)-N-[(4-carbamimi...)
Affinity DataIC50: 0.759nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306642BDBM306642(US10144746, Compound 285 | (1R,8S)-N-[(4-carbamimi...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306708BDBM306708(US10144746, Compound 400 | (1S,8R)-N-[(4-carbamimi...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306581BDBM306581(US10144746, Compound 224 | (1R,8S)-N-[(6-amino-2,4...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306647BDBM306647(US10144746, Compound 290 | (1R,8S)-N-[(4-carbamimi...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306648BDBM306648(US10144746, Compound 291 | (1R,8S)-N-[(4-carbamimi...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306538BDBM306538(US10144746, Compound 181 | (1R,8S)-N-[(6-amino-2,4...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306668BDBM306668(US10144746, Compound 312 | (1S,8R)-N-[(4-carbamimi...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306703BDBM306703(US10144746, Compound 392 | (1S,8R)-N-[(4- carbamim...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306658BDBM306658(US10144746, Compound 302 | (1R,8S)-N-[(4-carbamimi...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306565BDBM306565(US10144746, Compound 208 | (1R,8S)-N-{[6-amino-2-m...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306662BDBM306662(US10144746, Compound 306 | (1R,8S)-N-[(4-carbamimi...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306535BDBM306535(US10144746, Compound 178 | (1R,8S)-N-[(6-amino-2,4...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306663BDBM306663(US10144746, Compound 307 | (1S,8R)-N-[(4-carbamimi...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306536BDBM306536(US10144746, Compound 179 | (1R,8S)-N-[(6-amino-2,4...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306620BDBM306620(US10144746, Compound 263 | (1S,8R)-N-[(4-carbamimi...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306652BDBM306652(US10144746, Compound 296 | (1R,8S)-N-((4-carbamimi...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306685BDBM306685(US10144746, Compound 329 | (1R,8S)-N-[(4-carbamimi...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306558BDBM306558(US10144746, Compound 201 | (1R,8S)-N-[(4- carbamim...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306686BDBM306686(US10144746, Compound 331 | (1R,8S)-N-[(4-carbamimi...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306559BDBM306559(US10144746, Compound 202 | (1R,8S)-N-[(4- carbamim...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306528BDBM306528(US10144746, Compound 170 | (+-)-N-[(4-carbamimidoy...)
Affinity DataIC50: 1nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306544BDBM306544(US10144746, Compound 187 | (1R,8S)-N-[(4- carbamim...)
Affinity DataIC50: 1.74nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306671BDBM306671(US10144746, Compound 315 | (+-)-N-[(4-carbamimidoy...)
Affinity DataIC50: 1.82nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306593BDBM306593(US10144746, Compound 236 | (1S,8R)-N-[(4-carbamimi...)
Affinity DataIC50: 2nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306616BDBM306616(US10144746, Compound 259 | (1R,8S)-N-[(4- carbamim...)
Affinity DataIC50: 2nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306632BDBM306632(US10144746, Compound 275 | (1S,8R)-N-[(4-carbamimi...)
Affinity DataIC50: 2nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306490BDBM306490((+-)-N-[(6-amino-4-methoxy-2- methylpyridin-3-yl)m...)
Affinity DataIC50: 2nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306492BDBM306492((+-)-N-[(6-amino-4-ethoxy-2- methylpyridin-3-yl)me...)
Affinity DataIC50: 2nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306574BDBM306574(US10144746, Compound 217 | (1S,8R)-N-[(4- carbamim...)
Affinity DataIC50: 2nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306654BDBM306654(US10144746, Compound 298 | (1R,8S)-N-[(4-carbamimi...)
Affinity DataIC50: 2nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306643BDBM306643(US10144746, Compound 286 | (1S,8R)-N-[(4-carbamimi...)
Affinity DataIC50: 2.45nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306678BDBM306678(US10144746, Compound 322 | (+-)-N-[(6-amino-2,4-di...)
Affinity DataIC50: 2.69nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306497BDBM306497((1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-met...)
Affinity DataIC50: 3.02nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306530BDBM306530(US10144746, Compound 173 | (+-)-N-{[6-amino-2-meth...)
Affinity DataIC50: 3.02nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306475BDBM306475((+-)-N-[(6-amino-4-methoxy- 2-methylpyridin-3-yl)m...)
Affinity DataIC50: 3.98nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306494BDBM306494((+-)-N-[(6-amino-4-ethyl-2- methylpyridin-3-yl)met...)
Affinity DataIC50: 3.98nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306546BDBM306546(US10144746, Compound 189 | (+-)-N-[(4-carbamimidoy...)
Affinity DataIC50: 4.57nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306371BDBM306371(US10144746, Compound 13 | (+-)-N-[(6-amino-2,4- di...)
Affinity DataIC50: 4.79nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306672BDBM306672(US10144746, Compound 316 | (+-)-N-[(4-carbamimidoy...)
Affinity DataIC50: 4.90nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306625BDBM306625(US10144746, Compound 268 | (1R,8S)-N-[(6-carbamimi...)
Affinity DataIC50: 5.01nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306498BDBM306498((1R,8S)-N-[(6-amino-2,4- dimethylpyridin-3-yl)-met...)
Affinity DataIC50: 5.01nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306691BDBM306691(US10144746, Compound 336 | (1S,8R)-N-[(4-carbamimi...)
Affinity DataIC50: 5.01nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306604BDBM306604(US10144746, Compound 247 | (1R,8S)-N-{[6-amino-2-m...)
Affinity DataIC50: 5.01nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306704BDBM306704(US10144746, Compound 396 | (+-)-N-[(4- carbamimido...)
Affinity DataIC50: 5.01nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306693BDBM306693(US10144746, Compound 338 | (1R,8S)-N-[(4-carbamimi...)
Affinity DataIC50: 5.89nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306641BDBM306641(US10144746, Compound 284 | (1S,8R)-N-[(4- carbamim...)
Affinity DataIC50: 6.31nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

TargetPlasma kallikrein(Human)
Global Blood Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 306426BDBM306426(US10144746, Compound 68 | BDBM306427 | (+-)-N-[(6-...)
Affinity DataIC50: 6.31nMAssay Description:The chromogenic substrate D-Pro-Phe-Arg-pNa, 2HCl (BIOPHEN CS-31(02) from Hyphen BioMed, Neuville-Sur-oise, France) was dissolved in 5 mL deionized w...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/31/2019
Entry Details
US Patent

Displayed 1 to 50 (of 350 total ) | Next | Last >>
Jump to: